CD276 and pancreatic neoplasm: Although our pancreatic cancer patient cohort was much larger (137 patients) than most of the previous cohorts in which association between B7-H3 expression and prognosis was investigated (36, 39–42), we found no association between B7-H3 expression in cancer cells or in tumor stroma with cancer recurrence or patient survival.